Von Hippel-Lindau Disease Overview

Von Hippel-Lindau (VHL) disease is a genetic disorder causing tumors in various organs due to a mutation in a tumor suppressor gene on chromosome 3. It is inherited dominantly, with a 50% chance of passing the mutation to offspring. Tumors can be benign, like hemangioblastomas, or malignant, such as renal cell carcinoma. Diagnosis involves family history, imaging tests, and genetic testing. Treatment focuses on regular surveillance and may include surgery or targeted therapies. Pre-implantation genetic testing is an option for those wishing to avoid passing on the mutation.

What is the genetic cause of Von Hippel-Lindau disease?

• A mutation in a cell signaling gene on chromosome 9

• A mutation in a DNA repair gene on chromosome 7

• A mutation in a tumor suppressor gene on chromosome 3

• A mutation in a growth factor gene on chromosome 5

How is the VHL mutation typically inherited?

• Mitochondrial inheritance

• Autosomal dominant pattern

• X-linked recessive pattern

• Autosomal recessive pattern

Which type of tumor is most characteristic of VHL disease?

• Neuroblastoma

• Glioblastoma

• Hemangioblastoma

• Osteosarcoma

What symptoms might a pheochromocytoma cause in VHL patients?

• Hearing loss

• Loss of vision

• Skin rashes

• Headaches and high blood pressure

What is the first step in diagnosing VHL disease?

• Performing a skin examination

• Administering a blood test

• Conducting a detailed family history

• Performing a biopsy

Which imaging test is used to detect brain and spinal cord tumors in VHL patients?

• X-ray

• MRI

• PET scan

• Ultrasound

What is a key component of managing VHL disease?

• Annual blood transfusions

• Daily medication

• Regular surveillance with imaging tests

• Monthly chemotherapy

What is the goal of treatment recommendations for VHL disease?

• To completely cure the disease

• To prevent any new mutations

• To preserve organ function

• To eliminate all tumors

What option is available for individuals with VHL who wish to have children without passing on the mutation?

• Gene therapy

• Pre-implantation genetic testing

• Stem cell therapy

• Hormone replacement therapy

Why is routine screening important for VHL patients?

• To improve physical fitness

• To prevent genetic mutations

• To detect tumors early and manage them effectively

• To ensure a balanced diet